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Review of Literature

Introduction

Bone remodeling
The maintenance of bone mass in the skeleton depends on bone turnover. Bone
turnover is the result of many cycles of bone resorption and formation occurring locally
throughout the skeleton. Cycles are initiated by the arrival of bone resorbing cells,
osteoclasts, which resorb a packet of bone and then leave the scene probably via
apoptosis or programmed cell death. Osteoclasts are followed by bone forming cells,
osteoblasts, which lay down matrix proteins, mostly type I collagen, to replace the bone
that has been resorbed. This cycle is "coupled" because formation always follows
resorption as long as there is a template remaining. Orthodontically applied forces
attempt to manipulate this cycle and to remodel the bone surrounding a tooth such that
the tooth will be in a more favorable location.
Orthodontic tooth movement is generally explained by the pressure-tension
hypothesis, in which bone is resorbed on the areas under pressure and deposited at sites
of tension. [1] When a force is applied to the tooth, the tooth moves immediately 0.2-0.3
mm due to the compression of the periodontal ligament (PDL). The tooth remains in that
position, for several days, during which localized necrosis occurs in the compressed PDL.
Osteoclastic resorption that occurs in the bone marrow space adjacent to the area of
necrosis is called ''undermining'' bone resorption. After the removal of the necrotic PDL,
bone resorption in the area of compression occurs in the periodontal space. Once this
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frontal bone resorption is initiated, the tooth begins to move (Figure 1). [2] Biochemical
mediators that are induced in the surrounding cells further complicate the process of tooth
movement. For example, the cells of the compressed periodontal ligament secrete
cytokines, which stimulate osteoclastic formation and resorption in the direction ofthe
orthodontic force. [3] These cytokines not only stimulate bone resorption, but also
stimulate the production of prostaglandins (PGs), which are themselves potent
stimulators of resorption. [3] Applied mechanical load during tooth movement can also
induce prostaglandin production. [4] Prostaglandins have been shown to enhance tooth
movement under orthodontic forces, presumably by enhancing bone resorption. [4-8]
However, prostaglandins can also regulate bone formation and the integrity ofthe newly
remodeled bone surrounding the tooth will depend on the formation response to
resorption. Thus some of the sources of prostaglandin production may be from
compressed and fluid stressed cells in the PDL after orthodontic loading as well as from
cytokine stimulation from necrotic PDL tissues.

Bone Formation
For each new cycle of bone turnover, osteoblasts differentiate from multipotential
mesenchymal stem cells, in the bone marrow, into a series of precursor cells. [9] The
mature functioning osteoblast makes type I collagen, the major component of bone
matrix. It also produces bone specific non-collagenous proteins that are important for
mineralization. Consistent with its anabolic function, the osteoblast is characterized by a
great quantity of granular endoplasmic reticulum (ER), an abundance of free ribosomes, a
well-developed Golgi apparatus, and numerous mitochondria. [10] Once the osteoblast
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has completed its function, it can take one of three pathways. It can become an
osteocyte, a spidery cell that is trapped in mineralized bone, which cannot replicate
further. It can also become a lining cell, which covers the mineralized bone surface.
Finally, the osteoblast can undergo programmed cell death or apoptosis. [11]
According to studies by Stein and Lian [12], there are three very distinct and
sequential stages in the progression of an osteoblastic progenitor cell to a mature
osteoblast. The fIrst stage involves a period of rapid proliferation during which the
extracellular matrix (ECM) is synthesized and the number of cells presents increases.
When proliferation slows, precursor cells can then differentiate into cells that make
proteins characteristic of mature osteoblasts, such as osteocalcin and type I collagen. At
this point, the ECM undergoes development, organization, and maturation. Finally, the
ECM undergoes mineralization (Figure 2). [12]
The study of differentiation of osteoblastic precursors into mature osteoblasts can
be conducted using cultures of bone marrow cells or cultures of cells enzymatically

digested from calvariae. These primary calvarial cultures are thought to include a small
population of osteoblastic precursors. [13, 14] There are several generally accepted
markers of osteoblast proliferation and differentiation. The initial stage is characterized
by the production of cell cycle (histone) and cell growth (c-myc, c-fos, c-jun) related
genes that encode proteins that enhance active proliferation. Also, other genes
associated with the formation of the ECM such as type I collagen, are actively produced.
[12] The second stage is characterized by the expression of alkaline phosphatase (ALP),
an early marker for colony forming units-fibroblastic (CFU-f) units that can differentiate
to become osteoblasts. [12] Osteocalcin expression is a marker for the third period,
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matrix maturation, and corresponds with the increase in total mineral accumulation. [12]
Another marker of osteoblastic mineralization is the deposition of hydroxyapatite crystals
indicated by the von Kossa silver staining of the mineralized nodules. [15] The process of
osteoblastic proliferation and differentiation is regulated by many factors including
cytokines, mechanical stress, hormones, growth and differentiation factors, and cell-cell
and cell-matrix interactions. [16]
The osteocyte, the most abundant cell in the human bone, is about ten times more
prevalent than the osteoblast. [17] It is an "end stage" cell that can no longer proliferate
like the osteoblast but can make and secrete factors that can influence bone turnover.
Osteocytes are contained in a lacunar-canalicular system of bone in which the cell body is
contained in the lacuna and the cytoplasmic processes are housed in the canaliculi. The
osteoblast's progression to an osteocyte begins with a signal, possibly from another
recently embedded osteocyte, which stimulates an osteoblast to commit to osteocyte
differentiation while simultaneously directing a preosteoblast in the same area to
differentiate into a mature osteoblast to replace the former. [18] The osteocyte is
characterized by a decrease in the number of organelles, a reduction in the cytoplasmic
volume, and cellular body volume. [10] In addition, it acquires long slender processes,
which allow the osteocyte to communicate with other embedded osteocytes, as well as
with the lining cells [19] via gap junctions found on the cell bodies and on the
cytoplasmic processes. [20, 21]
As yet, the functions of osteocytes have not been conclusively determined.
However, one theory that is gaining credence is the possible role of osteocytes as
mechanosensory cells. Cowin et al. [22, 23] as well as Burger and Klein-Nulend [24]
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proposed that osteocytes are mechanically activated by the flow of interstitial fluid
through the lacuno-canalicular system (Figure 3).

Bone Formation in Alveolar Bone
The proliferation and differentiation of osteoblasts in the alveolar bone begin in
the periodontal ligament (PDL). The PDL is a connective tissue interface between a
tooth and its surrounding bone. It is largely composed of three substances: 1) collagen
fibers, 2) ground substance which is a gel-like matrix mainly of glycoproteins,
proteoglycans, and hyaluronan, and 3) fibroblast-like cells (FLC) (Figure 4). FLC
constitutes fifty percent of the PDL by volume [25] and contain a population of both
osteogenic and non-osteogenic cells. [26] The FLC in the PDL eventually give rise to
osteoblasts, cementoblasts, fibroblasts, and macrophages, as well as others that have not
yet been determined. [27] Roughly half of the FLC in the rat PDL contributes to the
population of osteoblasts. [28]
The active cell cycle is divided into four phases: (1) G 1, a period of pre-DNA
synthesis, (2) S phase, a time in which DNA replicates, (3) G 2 , a period of post-DNA
synthesis, and (4) M, the period of mitosis in which the cell divides producing two
identical daughter cells. [27] During the period of active proliferation, the approximate
duration of each phase is 21, 9, 2.5, and 1.2 hours respectively. [29] Non-cycling cells
may arrest at two points in the cell cycle. The frrst point, at the end of G 1 and prior to S
phase, is referred to as G 1 blocked. The second point, at the end of G 2 and prior to
mitosis, is called G2 blocked. Reserve cells in deep G 1 block are referred to as Go cells
(Figure 5). [27]
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Roberts and Chase studied osteogenesis in the PDL following mechanical
stimulation. They inserted orthodontic elastic between the upper first and second molars
of the rat causing compression both in front of the fIrst molar and behind the second
molar. They concluded that cells with osteogenic potential were originally dispersed
within the PDL. However, with the onset of mechanical stimuli, these cells began to
proliferate and differentiate into osteoblasts as they migrated to the bone surface. [30]
Specifically, there is a cyclic decrease, increase, and return to basal levels of S phase cells
within 15 minutes to 2 hours as measured by 3[H]-thymidine labeling index. [31]
Throughout the PDL, mitotic bursts were recorded as early as 2 hours and elevated
labeling indices were shown as early as 6 hours following a mechanical stimulus. Given
that the labeling and mitotic activity occurs within hours of the stimulus, it is believed
that there is a transient release of quiescent G 1 blocked (Go reserve cells) and G2 blocked
cells in the PDL. [32] In addition, since only about half of the initial group of osteoblasts
was labeled with 3H thymidine despite its availability, it indicated that there were
preosteoblasts already in the PDL that were destined to immediately progress into
osteoblasts. [30]
A more localized response follows at about 12 hours to several days poststimulus. This specific osteogenic response is prolonged and the cell proliferation is
localized to the immediate area of new bone formation. Peak DNA synthesis occurs at
about 20 to 22 hours and peak mitotic activity occurs at about 30 hours. Roberts et al
reasoned that these osteoblasts, due to the time delay, resulted from passage through the
cell cycle. [29]

7

Prostaglandins
Prostaglandins (POs) are potent and complex regulators of bone metabolism.
POs, abundant in bone, are produced primarily by osteoblasts and are derived from
phospholipids in the membrane bilayer. Phospholipase A 2 (PLA2) releases arachidonic
acid (AA) from the membrane phospholipids. [33] Prostaglandin G/H Synthase (PGHS)
or eye 10oxygenase (COX), the rate limiting enzyme in the conversion of AA to
prostanoids [34], converts AA to PGG2 via a cyclooxygenase reaction. The same enzyme
then reduces P002 to PGH2 in a peroxidase reaction. Finally, tissue specific intracellular
enzymes convert POH2 into the various prostaglandins (PGE2 , POD2 , POI 2 , and PGF2a)
(Figure 6).
Two forms of COX have been discovered, COX-I and COX-2. [35] Both are
located in the endoplasmic reticulum and the nuclear envelop and both have all the
structural features necessary for catalytic functions. [36] However, there are many
differences between COX-I and COX-2. Although these enzymes catalyze the same
reaction, they are encoded by separate genes [37, 38] and are expressed and regulated
differentially. In addition, COX-l and COX-2 may be able to use endogenous and
exogenous arachidonic acid differentially [39] and may be functionally coupled to
different trans-membrane phospholipases. [40] Most importantly, it has been established
that COX-1 gene expression is generally constitutive while COX-2 is inducible.
COX-1 is thought to produce prostaglandins necessary for daily "housekeeping"
functions such as renal blood flow maintenance, gastric cytoprotection, and platelet
aggregation. COX-1 gene expression is only moderately affected by the same factors that
affect COX-2 expression. [33, 34, 41] In contrast, COX-2 is considered to be the
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synthase involved with inflammation and other acute responses. As

suc~

it is often

undetectable in tissues at basal conditions but can be rapidly and transiently induced to
high levels by multiple factors. These factors include cytokines IL-1 [42-46], TNFa [44,
46], and IL-6 [47]; growth factors

TGF~

[42, 48], TOFa [42, 45], and FOF-2 [49];

hormones like parathyroid hormone (PTH) [43, 50, 51]; prostaglandins [43, 50-52] and
fluid shear stress. [24] Serum is also a stimulator of prostaglandin in cultured osteoblasts.
[48] Olucocorticoids [43, 48], retinoic acid [53], and the cytokines IL-4 and IL-13, [44,
54] inhibit COX-2 expression. COX-2 is highly expressed in bone and appears to be the
enzyme responsible for most prostaglandin responses in bone including inflammation.
[35]
In addition, COX-2 is thought to be involved with mitogenesis and cellular
differentiation. [55] The scientific literature has clearly documented that the continuous
use ofNSAIDs has reduced the risk of co10rectal cancer approximately 50% in humans.
[56-58] Not surprisingly, there was an increase in COX-2 expression in human colorectal
adenocarcinomas [59] and elevated levels ofCOX-2 proteins in colorectal tumors. [60]
One study used APC ~7l6 mice, which develop hundreds oftumors in the intestines, and
bred these mice to COX-2 KO mice. The result was an 80-90% reduction of tumors in
the COX-2 KO mice. [61] In addition, when the APe ~716mice were given a highly
selective COX-2 inhibitor (SC-58125), there was a significant reduction in tumors. [61]
Dubois et al. concluded that over-expression of COX-2, often seen in colorectal cancer,
prolonged the G 1 part ofthe cell cycle. By greatly increasing the time in G l and
inhibiting cell apoptosis, COX-2 over-expression could increase the length of time that
abnormal cells would exist and increase the chance for further mutations ofthat cell.
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Thus the prolonged survival of abnormal cells can favor sequential gene mutations that
could result in tumor development. [62] Others have shown that COX-2 inhibition may
induce apoptosis [63] while the addition of exogenous PGE2 reversed the induction of
apoptosis produced by COX-2 inhibitors. [64]

Prostaglandins and Bone Formation
The regulation of bone formation by prostaglandins appears to be quite complex.
The scientific literature is controversial in regards to the effects of prostaglandins on the
proliferation of osteoblasts. Some studies suggest that prostaglandins enhance
proliferation. In one study, PGE2 was added to cultures of primary osteoblast cells from
embryonic chick calvariae in the concentrations of 10 -8 to 10 -5 M. PGE2 caused a dose
related increase in proliferation as measured by 3[H] thymidine incorporation and total
DNA content of the cultures. [65] Another study by Chyun et al. showed that PGE2 at 10
-7M stimulated both DNA and collagen synthesis as shown by 3[H] thymidine and 3[H]

proline incorporation. In addition to its stimulatory effects, PGE2 also reversed the
inhibitory effects of cortisol to levels above control untreated cultures. [66]
Other investigators have found conflicting results. In UMR 106-01 rat
osteosarcoma cells, Fang et al. found that PGE2 inhibited mitogenesis. [67] Another
group reported that PGE2 at 10 -{j M decreased proliferation of the human osteoblastic
osteosarcoma cell line G292 and Saos-2. [68] Fujimori et al. reported that indomethacin
stimulated cell growth in MC3T3-El cells by blocking endogenous PGE2 synthesis. [69]
Interestingly, the same group later demonstrated a bi-phasic role of prostaglandins in
osteoblast proliferation. They found that while exogenous prostaglandins inhibited cell
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proliferation at 6 x 10 -8M and 6 x 10 -7M, in the osteoblastic cell line MC3T3-E1, there
was also a slight stimulation of cell growth at 6 x 10 -6 M. The addition of
cyclooxygenase inhibitors, such as acetyl salicylic acid (ASA), fluriprofen, and
piroxicam, enhanced cell growth. These results suggest that the cyclooxygenase
inhibitors may stimulate growth by inhibiting the production of endogenous
prostaglandins. [70] Baylink et al. also found biphasic effects of prostaglandin on
osteoblast proliferation. However, in contrast to Fujimori's studies, they found
stimulation of osteoblastic proliferation at lower concentrations (10-9 M) and inhibition at
higher concentrations (10~ M). [71]
The data on the effects of prostaglandin on the differentiation of osteoblasts are
more conclusive. Prostaglandins clearly enhance differentiation of osteoblastic
progenitors into mature osteoblasts. [10-12] Scutt et al. showed that the addition ofPGE2
to the cell cultures of marrow stromal cells increased osteoblast differentiation without a
corresponding increase in proliferation. [72] In rat calvarial osteoblasts, Kanecki et al.
found that PGE2 ir1hibited proliferation but stimulated differentiation. [73] Still another
investigator found that PGE2 stimulated both the proliferation and differentiation of
osteoblastic MC3T3-E1 cells. [74, 75] Despite the conflicting reports regarding the
effect ofPGE2 on proliferation, the majority of the literature agrees on the effect ofPGE2
on differentiation. Interestingly, although prostaglandins stimulate the differentiation of
osteoblasts, they generally inhibit the function of mature osteoblasts, such as the ability to
make collagen. [76, 77]
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Knockout Mice
Prostaglandins are a diverse group of autocrine and paracrine hormones that are
involved with many cellular and physiologic processes. In order to study the effects of
PGs, NSAlDs were used to inhibit its production. However, since different NSAlDs
affect both COX-1 and COX-2 to varying degrees [78], it was difficult to establish
whether or not the results ofthe study were due to the inhibition of COX-1 or COX-2.
Transgenic mice, in which the COX-lor COX-2 are disrupted, have been produced by
insertion ofa neomycin cassette in the location of the COX-lor COX-2 gene. [79-81]
COX-1 deficient or knock out (KO) mice develop normally and appear to be
healthy. Examination of the liver, spleen, kidney, gastrointestinal tract, reproductive
organs, heart and lungs reveal no major pathology. In some of the kidneys of the COX-1
KO mice, there were several areas characterized by immature tubules but the size and
frequency did not increase with age. They have no gastric pathology, show decreased
indomethacin-induced gastric ulceration compared to wild-type (WT) mice, and have a
reduced inflammatory response to exogenous arachidonic acid (AA). In addition, COX-1
KO mice have a reduced capacity for platelet aggregation in response to AA. Due to
parturition difficulties, breeding between COX-1 KO mice produce few live offspring.
[79]
COX-2 KO mice, on the other hand, may have a shorter lifespan primarily due to
renal abnormalities. Examination of the organs of the COX-2 mice revealed kidneys,
which were small, pale, and granular in appearance. Some areas showed immature
glomeruli while others showed areas of inflammation and atrophy. The severity of renal
neuropathy increases with age. The kidneys of3-day-old COX-2 mice did not differ
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from the kidneys of the WT mice. Thus it suggests that due to the presence of some
PGE2 in utero from the mother or other errlbryos, the development of the kidneys in
COX-2 mice occurred normally. However, with the birth of the COX-2 mice, the lack of
PGE2 prevented the further development of the kidneys resulting in renal problems,
which increased over time. [80] In addition to renal pathology, sporadic cardiac fibrosis
and increased susceptibility to peritonitis characterize COX-2 KO mice. COX-2 KO
females have multiple problems in the reproductive process, including absent ovulation,
due to the absence ofthe corpora lutea. Difficulties in fertilization, implantation, and
decidualization have also been noted. [82] Despite these problems, COX-2 mice have a
normal inflammatory response to AA and tetradecanoyl phorbol acetate (TPA) as well as
a normal inflammatory response to bacterial invasion of the peritoneum. [80]
COX-2 heterozygous (HT) mice survive and breed normally. Due to the
difficulties of producing live offspring from the breeding of female COX-2 KO mice,
[79, 80] knockout mice are obtained fron1 crossing ofHT mice.

Prostaglandins and Tooth Movement
In general, orthodontics tooth movement is considered to be a localized and
controlled area of inflammation. As discussed above, the reaction to the forces placed on
the tooth results in the release of such factors as prostaglandins, which results in the
inflammation process. As POs are postulated to stimulate resorption and are generally
considered to facilitate inflammation, the rate oftooth movement should increase with
PO administration. In 1990, Lee showed that the administration ofPGE 1 to rats, both
locally and systemically, enhanced bone resorption. [5] Davidovich et al. went one step
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further to show that the levels ofPGE2 increased in alveolar bone of cats during tooth
movement. [4] Yamasaki et al. showed a two-fold increase in the rate of tooth movement
with the injection ofPGE] and PGE2 in monkeys. [7] In limited clinical trials, buccal
injections ofPGE 1 produced 1.6-2 times more tooth movement when compared with
controls with minimal side effects. [8] Further studies showed that lower concentrations
ofPGE2 (0.1 or 1.0 micrograms) were as effective as higher concentrations (5.0 and 10.0
micrograms) in erlhancing tooth movement and that rats with single injections ofPGE2
showed similar results as rats with multiple injections. [83, 84]
Numerous studies showed that PGs ermance the rate oftooth movement. It would
then seem logical that inhibiting the production ofPGs would slow the rate oftooth
movement. Nonsteroidal anti-inflammatory drugs (NSAIDs) are a class of agents that
have anti-pyretic, anti-inflammatory, and analgesic properties. They act by blocking the
production ofPGs, and thereby reducing inflammation (Figure 7). [85] The older
NSAIDs inhibit both COX-l and COX-2 differently. For example, aspirin irreversibly
inactivates both COX-l and COX-2 but its effects are more profound on COX-I. [86, 87]
Aspirin also inactivates COX-2 by catalyzing the production of 15-HETE instead of
PGH2. [88, 89] Ibuprofen acts by reversible inhibition of both isoforms about equally
while the active metabolite ofnambutone preferentially inhibits COX-2. [55, 90] In
general, the older non-selective NSAIDs have anti-inflammatory properties but tend to
have gastrointestinal side effects. [91] COX-2 selective inhibitors have anti-inflammatory
properties with little gastrointestinal effects. [92, 93] There are two new COX-2
inhibitors on the market, Vioxx ™ and Celebrex TM. Since NSAIDs are routinely used for
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the treatment of orthodontic discomfort, its effect on tooth movement would be relevant
to the clinician.
Indomethacin, a potent inhibitor ofPG synthesis, is often used in the study of
prostaglandin inhibition. In one study, indomethacin was administered perorally to
miniature pigs undergoing tooth movement for a 39-day observation period. Histology of
the bone revealed that the extent of resorption was significantly reduced.

Formation

surfaces of bone were also reduced but not significantly suggesting that the rate of bone
turnover but not remineralization may be influenced by indomethacin. [94] In another
study, cats were given indomethacin orally and observed for 21 days. The rates of tooth
movement for the treated cats were two times slower that for the controls. Therefore,
NSAIDs may be contraindicated for patients undergoing orthodontic treatment. [95]

Hypothesis

We hypothesize that endogenous PGs produced by the induction ofCOX-2 act to
switch osteoblastic cells from the proliferative state into differentiating state. Therefore,
we expect osteoblastic cell cultures from COX-2 knockout mice (KO), in which the
COX-2 gene has been disrupted, to proliferate more rapidly than cells from wild type
mice with normal COX-2 gene expression (WT). We also expect osteoblastic cells from
COX-2 knockout (KO) mice to differentiate less rapidly than cells from wild type (WT)
mice. In addition, if exogenous PGs are added to the COX-2 cell cultures, the differences
between wild type (WT) and knockout (KO) cells should be reversed.

Objective

The purpose ofthis research is to determine the role of prostaglandins (PGs) in the
proliferation and differentiation of primary calvarial osteoblasts from COX-2 knockout
and wild type mice.

Specific Aims

1) To test the hypothesis that osteoblastic precursor cells from COX-2 knockout (KO)
mice proliferate more rapidly than those from COX-2 wild type (WT) mice and that the
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difference is due to the lack ofPGE2 production. We will use primary osteoblastic cells
obtained by enzymatically digesting calvariae from COX-2 KO and WT mice. We will
measure cell count using a Coulter Counter on sequential days of culture, beginning on
Day 3 and continuing until cell numbers have reached a plateau. We will measure PGE2
in the culture medium by Radioimmunoassay (RIA) to document differences in PGE2
production by WT and KO cells. We will treat KO cells with exogenous PGE2 (0.1 to 1.0
J.!M) to see if we can reverse the differences.

2) To test the hypothesis that osteoblastic precursors from COX-2 knockout mice
differentiate more slowly than those from COX-2 wild type mice and that the difference
is due to the lack ofPGE2 production. We will use primary osteoblastic cells obtained
by enzymatically digestion of the calvariae from COX-2 KO and WT mice. We will
measure markers of osteoblastic differentiation by the following methods: A) staining for
alkaline phosphatase (ALP) on sequential days of culture beginning on Day 6 B) Measure
ALP activity at the end ofthe fIrst and second weeks of culture. We will measure PGE2
in the culture medium by RIA to document differences in PGE2 production by WT and
KO cells. We will treat COX-2 KG cells with exogenous PGE2 (0.1 to 1.0 J.!M) to see if
we can reverse the differences.

Materials and Methods:

Breeding and Genotyping
As homozygous COX-2 KO female mice are infertile, heterozygous (HT) COX-2
mice were bred to obtain the COX-2 KO mice. The litters were typed using polymerase
chain reaction (PCR) amplification of DNA taken from tail snips. Litters contained three
genetic types: wild type (WT), heterozygous (HT), and knockout (KO). Each calvariae
were dissected and the primary osteoblast cells were harvested in the manner stated
below.

Primary Osteoblast (POB) Cell Culture
Whole calvariae were dissected from 5-12 week old COX-2 (WT, HT, KO)
littermates, and dissected free of loose connective tissue. After rinsing with PBS, the
calvariae were sequentially digested with 0.5 mg/ml crude collagenase and 0.01 %
trypsin- 0.5% mM ethylenediaminetetraacetic acids (EDTA) for 10 minutes at 37° C,
with the exception offifth digest which will be for 45 minutes. The enzymatic reaction
was stopped by 10% heat-inactivated fetal calf serum and the released cells were filtered
through a Nitex membrane to obtain a single cell suspension. As the first digest
contained a mixture of cells including fibroblasts [96, 97], it was discarded and only
digests 2-5 were saved. The cells from digests 2-5 were pooled, spun, resuspended, and
plated in 100 nun culture dishes in Dulbecco's modified Eagle's medium without phenol
red, 10% heat-inactivated fetal calf serum (lll-FCS), penicillin (100 U/ml), and
streptomycin (50 J.lg/ml).
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These cells were grown to confluence, with the culture medium to be changed
every 3-4 days. Once the cells were confluent, the cells were trypsinized from the culture
dish, split, and plated into 6 well dishes at 5000 cells/cm2 . The same medium, with the
addition of 50J.!g/ml phosphoascorbic acid (L-ascorbic acid phosphate magnesium salt;
Wako Pure Chemical Industries, Japan), was used for plating of these cells. The cells
were cultured up to 4 weeks with medium changes every 3-4 days.
For the prostaglandin studies, different concentrations of prostaglandin (PGE2)
were pulsed into each well at the time of plating. The control wells were similarly pulsed
with ethanol. Subsequent medium changes already had the prostaglandin incorporated
into the medium, thus eliminating the need for the addition of prostaglandin into each
well. In addition to the medium change every 3-4 day, 1 ml of the old medium was
collected from the control wells and frozen until use for RIA.

Cell Count
Each well was rinsed with PBS and trypsinized with trypsin-EDTA. Cells from each well
were collected into a 15-ml centrifuge tube. The cells were centrifuged and were
resuspended in 500 J.!l ofDMEM solution. An aliquot of 100 J.!l was taken from the
dispersed cell suspension and placed in a counting vial with 9.9 ml of the Coulter Counter
buffer solution. If there was a large pellet after centrifugation, the cells were resuspended
in 1000 J.lI ofDMEM solution with a subsequent 100-J.!1 aliquot for counting. The lower
limit set for the Coulter Counter was 12.0 J.!m. Before counting and in between the
different groups, several counts were made on the buffer solution as a control. The
Coulter Counter displayed a reading as the number of cells per mI. If the resuspension
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occurred in 500 J.lI of solution, then the true number of cells per well was half of what
was displayed. If the resuspension was in 1000 J.lI of solution, then the displayed number
was the true number of cells per well.

Alkaline Phosphatase (ALP) Staining
Alkaline phosphatase staining was done with a commercial staining kit (Sigma).
The cells in each well were rinsed with PBS, fixed with a solution of citrate solution,
acetone, and formaldehyde for 30-60 seconds. The cells were rinsed in water and the
excess moisture was ren10ved with a pipette. The alkaline phosphatase stain, a solution
of8.3% FRY, 8.3% napthol, 8.3% nitrite solution, and 75% water, was prepared from a
commercial kit. (Sigma) The stain remained on the cells for 15 minutes, in the dark.
After incubation, the cells were rinsed with water and allowed to air dry.

Alkaline Phosphatase (ALP) Activity
After the culture medium was removed, cells were rinsed three times with PBS
and scraped in 0.5 ml of CAT scraping buffer (40 nM Tris pH 7.4, 1 mM EDT A, 0.15 M
NaCI). The cells were centrifuged for 30 seconds and the supernatant was removed. The
cells were resuspended in 100 ml of lysis buffer (10 mM Tris-HCL buffer, pH 7.5, plus
0.1 % Triton X-lOa). The samples were subjected to 3 freeze-thaw cycles on dry ice and
centrifuge for 5 minutes. 10 J.lI of the supernatant were transferred into micro titer wells
and the sample volume was brought up to 20 J.lI with lysis buffer. 180 J.lI of the assay mix
containing 2 mM p-nitrophenol phosphate as substrate and 2 mM MgCl2 were added to
the sample wells and incubated at 37°C until the color developed (2 minutes to 2 hours).
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The absorbance was read every I5-min at 410 nM for an hour. AP activity was
determined relative to a standard curve, normalized to the soluble protein content of the
extracts and expressed as nmol/min/mg protein. Histochemical assessment of AP activity
was carried out on unfixed cultures using FRV-alkaline solution and fast red violet LB
base in Hel (Sigma protocol No. 86). After incubation for 30 min at room temperature,
cells were rinsed with PBS and fixed in methanol.

Prostaglandin Radioimmunoassay (RIA)
Medium was removed from the cultured cells prior to changing the medium and
frozen until use. PGE2 accumulation was measured using Radioimmunoassay (RIA).
[98] RIA for PGE2 was carried out using antibodies provided by Dr. Laurence Levine of

Brandeis University. Unknown and standards contained equal amounts ofBGJ-BSA.
3[H]-prostaglandins were used as tracer and the assays were run at antibody dilutions
providing 20-40% binding. The lower detection limit of the assay for PGE2 was
approximately 5 pg per tube or O. 14 nM in a 100 JlI sample, and the intra assay variation
was 6%. The assays were carried out at 4 0 C and free prostaglandins were moved with
dextran-coated charcoal. The values for unknowns were calculated from a standard curve
using the logit-Iog, curve-fitting computer program (simple RIA program, D. Rodbard,
BCTIC, Computer Code Collection, Nashville, TN). The data were presented as mean,
standard error, and significances of differences determined by student's t-test. The data
were presented as pg ofPGE2 /ml of medium.
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DNA Content and 3[H]-thymidine incorporation
Cells grown in six-well dishes were washed with PBS, extracted with 10 %
trichloroacetic acid, and digested overnight with 0.5 M NaOH at 4 DC. Aliquots were
neutralized with 0.5 M acetic acid, and after the addition of diaminophenylindole, DNA
content was determined fluorometrically (Fluorolite 1000, DynaTech Laboratories,
Chantilly, VA). The DNA content was calculated as micrograms of DNA per well for six
wells, and values were expressed as the mean ± SEM. [42] 3[H]-thymidine incorporation
was calculated as dpm/micrograms of DNA per well for six wells, and the values were
expressed as the mean ± SEM.

Statistical Analysis
The statistical significance of the differences among the means was determined by
analysis of the variance (ANOVA), with post-hoc comparison of more than two means by
the Bonferroni method. The computer program Sigma Stat was used to run the statistics.

Results

Phenotype of WT and KO Mice
The COX-2 WT (+/+) and KO (-/-) mice were 5-12 weeks old and appeared to be
healthy and active. The skeleton appeared to be normal and there was no significant
difference in size or weight (Table 1). No difference was found in the bone histology for
5-week-old COX-2 WT and KO mice (data not shown). In addition, there was no
statistical difference in serum creatinine levels indicating that kidney function in both the
WT and KO mice was normal (Table 1).

Cell Co"unt: Conlparison ofCOX-2 WT and KO primary osteoblastic cell cultures
To evaluate the differences in the cell count between cultures with and without
COX-2, primary osteoblastic cells enzymatically digested from calvariae (pooled
populations 2-5) from COX-2 WT and KO mice were plated at a density of 5000
cells/cm2 • The cells were cultured for a total of6 days; with the cell counts measured on
days 2, 3, 5, and 6 (Figure 8). At day 2, the WT cultures were significantly increased by
cell count relative to the KO cultures (p < 0.01). At day 3 however, the cell count from
the KO mice was 1.3 times higher than the cell count from the WT mice (p < 0.01). The
increased cell count of the KO cultures compared to the WT was also found on days 5
and 6 (p < 0.01). Other experiments confIrmed this increase in cell count in the KO cell
cultures relative to the WT cell cultures (Table 2). Seven cell count comparisons
between WT and KO cultures were made in four different experiments between days 5
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and 8 of cell culture. Six out of the seven comparisons showed a 1.2 - 4.5 fold higher
cell count in the KO cultures than the WT cultures (p < 0.05).
Despite the consistently higher cell counts in the KO group, there was a wide
variation in the cell counts between experiments for the same day of culture even though
initial plating density was the same for all experiments. One explanation for this
differential rate of cell growth among the experiments may have been due to the different
ages of the mice (5-12 weeks) from which the calvariae were harvested. It was possible
that the primary osteoblastic cells digested from the calvariae of younger mice grew more
quickly. However, the differential cell counts among the experiments appeared to have
no direct relationship to the ages of the mice (Table 2). In fact, cultures from younger
mice appeared to grow more slowly.
To evaluate the differences in the cell count between cultures with varying
amounts ofCOX-2, we measured the cell counts from COX-2 WT (+/+), HT (+/-), and
KO (-/-) cell cultures. The cells were cultured for 3, 4, 6, and 7 days (Figure 9).
Throughout the 7 days of culture, the KO cultures had significantly greater cell counts
than the WT cultures (p < 0.01). The HT cultures had significantly lower cell counts than
the KO cultures at day 6 (p < 0.05), and higher cell counts than the WT cultures on days
3 (p < 0.05), day 6 (p < 0.01), and day 7 (p < 0.05). Thus, the HT response appeared to
be intermediate between that of the WT and KO cultures.

Role ofPGE 2 in the cell count difference between WT and KO primary osteoblastic cell
cultures
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We have previously shown [48] that fresh serum-induced expression ofCOX-2
and COX-2 associated PGE2 production in cultures osteoblasts. To determine if the
absence ofCOX-2 expression resulted in the difference of endogenous PGE2 in WT and
KO cultures, the medium ofthe cell cultures were sampled on days 3 and 7 and
radioimmunoassay (RIA) was conducted to measure the levels ofPGE2 (Figure 10). On
day 3, PGE2 in the medium of the WT cell culture was 70 ± 2.2 nMlwell but levels in the
medium of the KO cell culture undetectable « 0.1 nM). Culture medium with fresh
serum was replaced after measurement on day 3. On day 7, the levels of medium PGE2
in the WT cell culture were reduced by about 70 % as compared to day 3. Once again, the
levels of medium PGE2 in the KO cell cultures were undetectable. For both day 3 and
day 7, the differences between the levels of medium PGE2 between the WT and KO cell
cultures were significant (p < 0.01). The decreased PGE2 levels on day 7 probably
reflected the decreased ability of fresh serum to stimulate COX-2 expression with
increasing days of culture, a relationship that we have observed previously (data not
shown).
To study the effects of exogenous PGE2 on the cell count, primary osteoblastic
cells from COX-2 WT and KO mice were cultured for 7 days. Beginning from the day
the cells were plated, both WT and KO cells were treated with vehicle or PGE2 (10-6 M).
Fresh PGE2 and vehicle were added when the media was changed. Cell counts were
measured on days 3, 4, 6, and 7 (Figure 11). Throughout the 7 days of culture, there were
no differences in cell count between the WT control and the WT cultures treated with
PGE2 (10-6 M) cultures. PGE2 completely reversed the increased cell count seen in the
KO cultures on day 3. The cell counts from KO cultures treated with PGE2 were 40%
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less than the cell counts ofthe KO group on days 4 and 6 (p < 0.01) as well as for day 7

(p < 0.05). The cell counts from KO cultures treated with PGE2 were significantly higher
than the WT control group on all days except day 7 (p < 0.01). Thus, the addition of
PGE2 (10-6 M) to the KO cultures significantly reduced the cell number (p < 0.01) but
had no effects on WT cultures. However, the exogenous PGE2 at 10-6 M only partially
reversed the increased cell count in KO cultures.
Comparisons of the above data with two other experiments showed the mixed
results (Table 2). As stated above, experiment 14261 showed that PGE2 partially
reversed the increased cell counts ofthe KO cultures for day 6 and 7 (p < 0.05).
Conversely, results from experiment 14369 showed that, for day 8, PGE2 did reduce cell
counts ofthe KO cultures but it was not significant. Finally, results from experiment
14533 showed no effect ofPGE2 on KO culture's cell count for day 5 and 6. In fact,
there was even a slight increase in the cell count of the PGE2 treated KO cultures on day
6. All three experiments did show a significant increase in cell count for KO cultures
relative to WT cultures (p < 0.05) with the exception of experiment 14533 at day 6.
As noted in the literature, exogenous PGE2 has a complex effect on osteoblastic
proliferation, with hi-phasic effects dependent on the concentration ofPGE2 [70]. Hence,
we examined the effects ofa lower concentration, 10-7 M, ofPGE2. Primary osteoblastic
cells from COX-2 WT and KO mice were cultured for 6 days. Beginning from the day
the cells were plated, both WT and KG cells were treated with PGE2- Fresh PGE2 and
vehicle were added when the media was changed. Cell counts were measured on days 2,
3, 5, and 6 (Figure 12). PGE2 (10-7 M) had no effect on cell count in the cell counts from
the WT cultures except for day 3, which showed that the treated cultures had cell counts,
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significantly lower than the untreated WT cultures. However, the increased cell count in
the KO cultures relative to the WT cultures was completely reversed by the addition of
PGE2 at days 5 and 6.

Measurement of 3 [H]-thymidine incorporation in primary osteoblastic cell cultures from
WT and KO mice
The differences in the cell numbers between the WT and KO cultures can be
explained in two ways. The difference could be due to greater cell replication in the KO
cell cultures or to more apoptosis in the WT cells cultures. Total DNA content was
measured so that the 3[H]-thymidine incorporation could be normalized to account for
more or less DNA in some cultures. The measurement of 3[H]-thymidine incorporation
into the DNA estimates the number of cells passing through the S phase of the cell cycle
and therefore the rate of cell replication (Figure 5). This is a method of evaluating the
relative number of cells in the WT and KO cultures.
Total DNA content and 3[H]_ thymidine incorporation were nleasured for COX-2
WT and KO primary osteoblastic cell cultures on day 7 (Figure 13). Two different
experiments showed that the KO cell culture had 2 and 3 tinles more DNA than the WT
cell cultures (p < 0.05 and p < 0.01 respectively). This suggested that the KO cultures
had more cells than the WT cultures, consistent with the cell counts. The measurement
of 3[H]-thymidine incorporation, however, showed no difference between the WT and
KO groups. These results indicated that, at those particular time points, there were no
differences in the rates of replication between the WT and KO cell cultures. In a third
experiment, total DNA content and 3[H]-thymidine incorporation were measured on day
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5 (Figure 14). There was approximately double the amount of DNA in the KG control
cultures relative to the WT cultures (p < 0.01). This was again consistent with the 1.8
time greater number of counted cells in the KG cultures as compared to the WT cultures.
However, there was no difference in 3[H]-thymidine incorporation between the WT and
KO cell cultures. Thus there was no difference in rate of replication of the WT and KG
cell cultures at this particular point in time.
The effects of exogenous PGE2 on total DNA content and 3[H]-thymidine
incorporation were also measured on day 5 (Figure 14). On the day of plating, both WT
and KO cell cultures received PGE2 (10-6 M) and vehicle. Subsequent additions ofPGE2
and vehicle were given during media changes. There were no significant differences in
the measurement of 3[H]-thymidine incorporation between PGE2 treated and untreated
WT and KG groups. The treatment ofthe KO cultures with PGE2 resulted in about 40 %

reduction oftotal DNA relative to the control cell cultures (p < 0.01). However, there
was no difference in cell count between the KO cultures treated with PGE2 and untreated
cultures on that day. As discussed earlier, Dubois et al. found that over expression of
COX-2 increased the length oftime a cell spends in 0 1 stage ofthe cell cycle and
inhibited apoptosis [62]. Another study found that inhibition ofCOX-2 might induce
apoptosis [63]. However, these studies do not provide an explanation for the discrepancy
between the data on DNA content and cell count. It is possible that other alterations in
the cell cycle had occurred as a result of presence or lack ofCOX-2. One possibility is
that the untreated KO cells were delayed in S phase of the cell cycle, in which DNA was
duplicated. This would explain the similar cell counts of the POE2 treated and untreated
KO cultures as well as the 2-fold level of DNA content in the KO control cultures.
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Another possibility could be that PGE2 treated KO cells were delayed in G 1, the stage
prior to the synthesis of DNA. This could again provide an explanation for the similarity
of cell count and the differences in DNA content.

Comparison of osteoblastic differentiation in WT and KO calvarial osteoblastic cell
cultures
Alkaline phosphatase is a marker for early osteoblastic differentiation. In order to
compare the differences in osteoblastic differentiation, alkaline phosphatase (ALP)
staining was done on WT and KG cell cultures (Figure 15). On day 6, there was a clear
difference in staining between the two groups. The WT cell cultures showed distinct
evidence of alkaline phosphatase staining whereas the KO cultures did not show any
evidence of staining. By day 9, the difference between the two groups was no longer so
clear. It appeared that ALP staining, which measured differentiation, was delayed rather
than prevented in the KO cultures. By as early as day 9, the difference in staining was no
longer evident. In addition to the intensity of staining, there was a difference in staining
pattern of the cultures in all experiments. The KO group showed more staining in the
middle of the wells whereas the WT groups showed more uniform staining. One reason
for this pattern of staining may be a result of the differences in proliferation between the
WT and KO cultures. The rapid increase in cell count in the KO group may have led to a
greater confluence in the center of the wells. As a result, the confluent cells in the center
of the wells began to differentiate while the cells along the edges of the wells continued
to proliferate thus leading to the ALP staining pattern described above.
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ALP activity is a more quantitative measure of osteoblastic differentiation than
ALP staining. ALP activity was measured for WT and KO cells cultured for day 7 and
14 (Figure 16, 18). Two different experiments showed that the levels of ALP activity of
the WT cultures were 10-17 fold higher than the KO cultures on day 7. The difference in
ALP staining at day 7 was consistent with the increase in ALP staining of the WT
cultures in the fIrst week of culture (Figure 15). At day 14, there was no difference in the
levels of ALP activity for the WT and KO cultures in both experiments (Figure 16, 18).
Again, this was consistent with the results of the ALP staining, which showed that by as
early as day 9, the staining of both WT and KO cultures was roughly equivalent.

Effect ofPGE2 in the differentiation ofWT and KO primary osteoblastic cell cultures
Because COX-2 KO cultures make little PGs as stated above, we added PGE2
back to the cultures to see if we could reverse the effects ofCOX-2 KO on
differentiation. ALP staining was done on cultures treated with PGE2 (10-6 M) and
vehicle on day 7 (Figure 17). As shown above, there was a marked difference in staining
between the WT and KO control cell cultures. The addition of PGE2 (10-6 M) to the KO
cultures largely reversed this difference, producing similar levels of staining in both
groups. As discussed above, staining appeared to be concentrated in the middle of the
wells of the KG cultures.
In another experiment we examined ALP staining on days 7 and 14. There
appeared to be a very slight increase in staining ofWT cultures treated with PGE2 for
both days 7 and 14 (Figure 18). At day 7, there was a smaller difference in the intensity
of ALP staining between the WT and KO control cell cultures than seen in the previous

30

experiments. The addition ofPGE2 (10-6 M) again increased the level of the staining in
the KO cell cultures, which was even slightly more intense than the WT control and WT
PGE2 groups. By day 14, the intensity of the WT control, WT PGE2 , and KO control
groups were about equivalent. However, the KO PGE2 group continued to show a
relatively greater degree of staining.
Interestingly, the addition ofPGE2 (10-7 M) showed a different pattern of ALP
staining (Figure 19). At day 6, PGE2 (10-7 M) only partially reversed the decreased
staining in KO cultures relative to the WT cultures. By day 9, both treated and untreated
KO cell cultures showed approximately the same levels of staining with each other.
However, the staining in the WT PGE2 groups was slightly more increased relative to the
WT control cultures. Once again, the difference in pattern of staining between the WT
and KO was present.
The effects of exogenous PGE2 (10-6 M) on ALP activity were measured on days
7 and 14 in two different experiments (Figure 16). The addition ofPGE2 to the WT
cultures increased the levels of ALP activity 2-3 fold on both day 7 (p < 0.01) and day 14
(p < 0.05) whereas the ALP staining which showed no differences in the quantity of
staining between the WT control and PGE2 groups on day 7 (Figures 17,18). The
addition ofPGE2 to the KO cultures increased the levels of ALP activity 18 times for day
7 and 4 times for day 14 (p < 0.01). These results are consistent with the ALP staining
(Figures 17,18), which showed that exogenous PGE2 promoted staining and thus the
differentiation of the KO cultures.
In another study, ALP activity was measured for days 7 and 14, and produced
different results from the ones above (Figure 20). At day 7, the levels of ALP activity
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for the WT cultures were 10 times greater than the KO cultures (p < 0.01). However,
there was no difference in ALP activity between the WT and KO cultures at day 14.
PGE2 increased the ALP activity about 30% in WT cells on day 7 but reduced the levels

about 30% on day 14. These differences between the treated and untreated groups were
not significant and were consistent with the results of ALP staining which showed no
difference in the intensity of ALP staining (Figures 17,18). On day 7, the addition of
PGE2 to the KO cells increased ALP activity approximately 5 times as compared to

untreated KO cells (p < 0.01). On day 14, PGE2 had no effect on ALP activity in the KO
cultures, contrary to the staining which showed a slight increase in staining in the KO
cultures with the PGE2 (Figure 18). The similarities in the levels of ALP activity on day
14 may indicate that the differences in the ALP staining of the KO cells seen in the
earlier days may disappear over a longer period of culture.

Discussion
In the past, the ways in which investigators studied the impact of prostaglandins
on the proliferation and differentiation of osteoblastic cells were limited. In order to
study the effects of the absence ofPGs, NSAIDs were used to block the production of

POSe However, NSAIDs can have other effects on cells in addition to their inhibition of
PG synthesis, which may have masked the effects ofPG inhibition in these experiments.
Recently, the introduction ofnuce with the genes for COX-lor COX-2 disrupted has
made it possible to study the role ofPGs without the complications of the effects of
NSAIDs. We focused on COX-2 KO mice because our lab has previously shown that
COX-2, not COX-I, is the enzyme responsible for PG responses in bone cells.
Using primary calvarial cells from COX-2 WT and KO mice, we found that
endogenous prostaglandins had profound effects on the proliferation of osteoblastic cells.
We found, on average, a 2-fold higher cell count in the KO cultures compared to the WT.
RIA of the medium from these cultures showed high levels ofPGE2 in the WT but
undetectable levels in the KO cell culture medium. We concluded that the absence of
COX-2, and therefore endogenous PGs, was associated with an increase in the cell count.
The addition ofPGE2 had variable effects on the cell count, depending on the
concentration. PGE2 (10-7 M) completely reversed the increased cell counts in the KO to
the level of the WT whereas PGE2 (10-6 M) partially, but significantly, reversed the cell
counts in the KO cultures. Since exogenous PGE2 could reverse the effects ofthe
absence ofCOX-2, it suggests that the higher cell counts in the KO cultures were a result
of the absence ofPGE2 generated by COX-2.
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Our studies have shown that there was an increase in cell counts in the COX-2
KO cultures. One explanation for the difference in cell count is an increase in the rate of
replication by the COX-2 KO cells. As discussed earlier, the relationship between PGs
and osteoblastic proliferation is complex. Previous studies in osteoblasts have shown that
PGE2 increased proliferation [65, 66]; decreased proliferation [67, 68], or both [70, 71].
Our studies showed no increase in the rate of replication for the COX-2 KO cultures on
days 5 and 7. It is possible that we had missed the period in which the increase in
replication occurred. In order to minimize the likelihood of missing this stage, we can
measure the TDR at more frequent and earlier days of culture.
Another explanation for the increase in cell count in the COX-2 KO cells is that
there was a decrease in apoptosis in the KO cells. However, data from non-bone cells
suggest that COX-2 produced PGs, which decreased apoptosis. As discussed earlier,
several studies have shown that the over-expression of COX-2 and, thus an overabundance ofPG's, led to a decrease in apoptosis. Dubois et al. stated that overexpression ofCOX-2, often seen in colorectal cancer, prolonged the G 1 phase of the cell
cycle of rat intestinal epithelial cells by 3-fold. They concluded that by greatly increasing
the time in G 1, the lifespan of the cell was extended and apoptosis reduced. [62] Sheng et
al. stated that SC-58125, a selective COX-2 inhibitor, reduced colony formation of
human colon cancer cells and that the inhibition of growth was reversed by the addition
ofPGE2 • Furthermore, they reported that PGE2 inhibited the apoptosis caused by SC58125. [64] Another study by Hanifet al. also found that NSAIDs, specifically sulindac
sulfide and piroxicam, reduced proliferation and apoptosis of human colon cancer cells
and changed the cell cycle phase distribution. However, they concluded that the ability
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ofNSAIDs to reduce the rate of proliferation of these colon cancer cells were
independent ofthe PG synthesis pathway. [99]
From our studies, we have some limited data that may suggest that the absence of
COX-2 decreased the number of dead cells. Assuming that living cells would adhere to
the bottom ofthe wells but that dead cells would be floating in the media, we collected
medium from the cultures and measured the floating cell count. We found that there was
twice the number of cells in the medium ofthe WT cultures compared to the KO,
suggesting that there was double the number of dead cells in the WT cultures.
To determine the cause ofthe increase in cell number in the COX-2 KO cultures,
further studies on the role of apoptosis in COX-2 KO cells is necessary. In order to
evaluate cellular apoptosis, three techniques may be used: 1) measurement of DNA
content by propidium iodide staining and flow cytometric analysis; 2) acridine orange
staining; and 3) agarose gel electrophoresis of genomic DNA. [99]
It is also possible that expression ofCOX-2 simply delays cells in G t , as
suggested by Dubois. [62] Thus, COX-2 KO cells would simply progress more rapidly
through mitosis. In order to see if a delay in the cell cycle contributed to the difference in
cell count, it would be necessary to synchronize the cell cycles of the cells. Serumdepriving the cells can place them in a quiescent state. Once serum was introduced, the
cells should theoretically begin the cell cycle at the same point. IfTDR was measured at
frequent intervals, as often as every hour, the rates of replication of the WT and KO cells
can be measured and any delays in a cell cycle can be established.
Endogenous PGs also had major effects on the differentiation of osteoblastic cells.
The absence ofCOX-2, and consequently measurable PGE2 , inhibited the differentiation
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of cells as measured by ALP staining at the end of the first week of culture. We also
found that, at the end of the fIrst week of culture, the levels of ALP activity in the WT
cultures were 10-17 times greater than in the KO. The difference in differentiation, as
measured by ALP staining, appeared to disappear by about day 9. In one experiment, the
differences in ALP activity between the WT and KO were no longer significant by day
14 but there was still about a 25% decrease in ALP activity in the KO compared to the
WT.
The addition of exogenous PGE2 (10-6 M) to the KG cultures appeared to reverse
or speed up the differentiation of the KO cells to the level of the WT. However, the
addition of PGE2 to the WT cultures almost tripled ALP activity levels compared to the
untreated WT cultures. Therefore, PGE2 partially but significantly reversed the delay in
differentiation ofthe KO cells. In contrast to the above results, adding PGE2 (10-7 M)
showed no increase in differentiation ofthe KO cultures at day 6, as measured by ALP
staining. This suggests that the effects ofPGE2 on differentiation may be related to its
concentration. It is also interesting to note that while PGE2 (10-7 M) corrects the elevated
cell count in the KO cultures, it takes a higher concentration ofPGE2 (10-6 M) to correct
the delay in differentiation ofthe KO cells.
The effects ofPGs in cells are enormously complex thus making it very difficult
to study. One reason is that there is uncertainty about which endogenous PGs are
produced in addition to PGE2 by COX-2 WT cells. Therefore, simply adding back PGE2
may not compensate for the missing PGs. There are also different receptors for different
PGs, and hence, different PGs can stimulate different pathways. Finally, COX-2 might
have effects independent ofPG production as noted above. [99]
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Studies done in our lab showed that the bone histology of 5-week-old COX-2 KO
mice revealed no skeletal abnormalities. These results suggest that COX-2 is not
necessary for normal bone or skeletal development because the circulating levels of
maternal PGs may be sufficient to compensate. However, at 3-5 months of age, our
studies suggest that there is a reduction of bone mass in mice with deficient COX-2
relative to wild type mice. [100] Thus the absence ofCOX-2 appears to have an impact
on bone turnover bone. Studies in our lab have also shown that PGs produced by COX-2
are potent stimulators of bone resorption and required for maximal stimulation of
osteoclastogenesis by other agonists. [100] Hence, in vivo, deficient COX-2 may
decrease bone formation more than bone resorption.

Significance
Orthodontics involves the movement of teeth through bone. Biologically, tooth
movement is an inflammatory process in which the alveolar bone surrounding the tooth is
remodeled in such a way that the bone on the surface under pressure is resorbed and the
bone on the surface under tension is deposited. The placement of forces, in an attempt to
control the areas of resorption and deposition, is what allows the teeth to move through
the bone into a fmal esthetic position. This remodeling of bone is an intricate and
complex process, which is controlled by an array of mediators.
Over the years, orthodontics, as in other medical and dental fields, has evolved for
the better. Advancing technology has produced appliances and new materials that have
improved results and reduce treatment time. One example of such an advance is the
nitinol wire, which has tremendously simplified the process of aligning and leveling.
However, there may be a biological threshold beyond which bone remodeling, and
therefore tooth movement, cannot occur more quickly. Yamasaki et al. [7, 8] have shown
that the rate of orthodontic tooth movement increases with local injections ofPGE2 in
monkeys and local injections ofPGE] in humans. In addition, PG antagonists have been
shown to reduce the rate of tooth movement by inhibiting the increase of osteoclasts on
the resorptive surface [6] and the differentiation of osteoblasts on the bone-forming
surface. [101] Consequently, the future of orthodontics may lie in improving the rate of
bone remodeling. The subsequent reduction of treatment time may potentially minimize
side effects of orthodontic treatment, such as periodontal disease, enamel
demineralization, and root resorption. In addition, a more complete understanding of
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how prostaglandins regulate bone resorption and formation may lead to the development
of new therapies.
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Table 1. Comparison of body weights and serum creatinine levels from mice with
both COX-2 alleles intact (WT), one allele intact (HT) or both alleles disrupted
(KO). Adapted from Okada et ale [103]

Gel10t)'pe (11)

Bod)' "eigllt (gill)

S(-'I'"lJIIl

C.'"eat il1il1e

(IIlg/dl)

COX-2 Wild Type
(WT)

16.7 ± 1.7

0.93 ±0.O2

COX-2
Heterozygous
(HT)
COX-2 Knockout

16.6± 0.9

0.93 ± 0.01

15.1 ± 1.9

O.96± 0.04

(KG)

Data are means ± SEM for 5-wk old C57BI/6 X 129 mice. Each group includes
2 males and 2 females from 2 litters.

C

C

C

257,000
±22,690

386,133

-

-

50,600
±3189.6

(1.2 X)
39,900
± 1,914

827,367

±50,889

819,400
± 36,418

D6
WT

(1.8 X)
396,067
±23,299
(1.5 X)

43],733
±38,826

±13,734 • ±7,585

450,267

-

-

-

-

885,067
± 66,740·
(1.8 X)
495,133
±21,783 c
(1.2 X)

KO

479,933
±21,776
(1.2 X)
502,933
± 22,822
(1.2 X)

-

-

(4.5 Xl
127,133
±6,664 c:
(2.5 Xl

-

-

123,733

WT

D7

-

-

-

-

115,167
± 12,679

± 10,024 • ± 15,623

178,800

1,150,000
±55,076·
(1.4 X)
717,267
±29,459 c:

KO

-

-

-

-

-

-

(2.1 Xl
160,633
.± 19,189·
(1.4 X)

± 19,713 •

256,400

KO

Data are means and SEM for n=3
Data in paranthcsis are fold increase in cellslmVwell compared to opposite group
• Significant difference from WT, P < 0.01
c: Significant difference from KO, P < 0.01
~ Significant difference from WT, P < 0.05
• Significant difference from KO, P < 0.05

(10-' M)

PGE2

Donor age:
7 wks

248,933

±9,624

C

-

-

-

-

405,867
±39,683

482,667
±40,175

14533

EXPT

Donor age: PGE2
51/2-8 wks (10-6 M)

EXPT
14369

Donor age: PGE2
(10-6 M)
5 wks

14261

EXPT

Donor age: PGE2
(10.7 M)
12 wks

14168

EXPT

WT

D5

-

-

-

-

-

-

44,825
±482

55,492
± 4,987

D8
WT

-

-

(3.9 X)
120,258
± 13.781
(2.1 Xl

214,275

-

-

-

-

± 49,248 It

KO

Table 2. Summary of Cell Count (cellslml/well) Data for Wild Type (WT) and COX-2 Knockout (KO) Calvarial Osteoblastic
Cultures
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Figure 1: Adapted from Soma et al. [2] Orthodontics tooth movement. A) Placement of

a force produces 0.2-0.3 mm of initial tooth movement due to the compression of the
periodontal ligament (PDL). B) Necrosis of the PDL (shaded areas) and undermining
bone resorption occurs. Tooth movement is arrested because of the lack of bone
resorption in the PDL. C) After the removal of necrotic tissue and completion of
undermining resorption, the tooth moves continously by bone resorption. The arrow
indicates the direction of the force and tooth movement.

Figure 2: Adapted from Stein et al. [15] Model of the relationship between osteoblastic

proliferation and differentiation. There are three sequential stages through which
osteoblastic precursor cells progress into a mature osteoblast. As proliferation of the
osteoblastic precursor cells decrease, differentiation begins. Markers of osteoblastic
differentiation such as Type I collagen, alkaline phosphatase, and osteocalcin begin to
be expressed.

Figure 3: Adapted from Burger and Klein-Nulend [25]. Model for mechanotransduction

in bone. Stress (large arrows) placed on the mineralized matrix (MM) produce strain
that squeeze fluid through the lacuno-canalicular system (small arrows). The network
consists of osteocytes (OCY) located in the MM and osteoblasts (OB) on the bone
surface by cell processes and gap junctions.
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Figure 4: Adapted from Embery et al. [104] Periodontal ligament. The periodontal
ligament (PDL) is a connective tissue interface between a tooth and its surrounding
bone.

Figure 5: Cell cycle for orthodontically activated fibroblast-like cells in the periodontal
ligament of a rat molar [106]. When an orthodontic load widens the periodontal
ligament (PDL), quiescent cells located at the end ofG1 (also known as Go) and G 2 ,
are recruited into the cell cycle to proliferate. Gl is the pre-synthetic phase. DNA is
replicated in the S phase. G2 is the post-synthetic phase. Cells divide in the M or
mitotic phase. Some of these cells differentiate to become osteoblasts while other
less differentiated cells continue though the cell cycle.

Figure 6: Prostaglandin production pathway. Cyclooxygenase (COX) converts
arachidonic acid (AA) from the membrane bilayer to PGH2 in a cyclooxygenase and
peroxidase reaction. PGH2 is then converted into various prostaglandins by a number
of different tissue specific intracellular enzymes. Two forms of COX, COX-1 and
COX-2 exist. Although they are 60% honlologous and catalyze the same reaction,
they are encoded by different genes and are expressed and regulated differentially.

Figure 7: Inhibition of the prostaglandin pathway by non-steroidal anti-inflammatory
drugs (NSAIDs) [86]. NSAIDs act by preventing the conversion of arachidonic acid
to PGH2 by cyclooxygenase (COX) and thus preventing the production of
prostaglandins.
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Figure 8: Cell count (cells/ml/well) in COX-2 wild type (WT) and knockout (KO)

primary calvarial cell cultures. Data are means

± SEM for 3 wells.

a

Significant

difference from WT, P < 0.01.

Figure 9: Cell count (cells/ml/well) in COX-2 wild type (WT), heterozygous (HT), and

knockout (KO) primary calvarial cell cultures. Data are means ± SEM for 3 wells.
a

Significant difference from WT, P < 0.05.

b

Significant difference from HT, P < 0.01

Figure 10: PGE2 (nM) in the medium ofCOX-2 wild type (WT) and knockout (KO)

primary calvarial cell cultures. Fresh medium was added after the media was collected
for measurement on day 3. PGE2 was measured by RIA. Bars are means

± SEM of 3

wells. UD: undetectable

Figure 11: Effects of exogenous PGE2 (10-6 M) on cell count (cells/ml/well) in COX-2

wild type (WT) and knockout (KO) primary calvarial cell cultures. PGE2 was added at
the beginning of culture and at each medium change. Data are means ± SEM for 3 wells.
a

Significant difference from WT, P < 0.01.

b

Significant effect of PGE2 (10-6 M),

P < 0.01.

Figure 12: Effects of exogenous PGE2 (IO-7 M) on cell count (cells/ml/well) in COX-2

wild type (WT) and knockout (KO) primary calvarial cell cultures. PGE2 was added at
the beginning of culture and at each medium change. Data are means

± SEM for 3 wells.
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a

Significant difference from WT, P < 0.05.

b

Significant effect ofPGE2 (10-7 M),

P < 0.01.

Figure 13: Comparison of DNA content and 3[H]-thymidine incorporation in COX-2
wild type (WT) and knockout (KO) primary calvarial cell cultures on day 7 of culture.
Data are means ± SEM of3 wells.

a

Significant difference from WT, P < 0.01.

Figure 14: Effects of exogenous PGE2 (10-6 M) on DNA content and 3[H]-thymidine
incorporation in COX-2 wild type (WT) and knockout (KO) primary calvarial cell
cultures on day 5 of culture. PGE2 was added at the beginning of culture and at each
medium change. Data are means ± SEM for 3 wells.
P < 0.01.

b

a

Significant difference from WT,

Significant effect ofPGE2 (10-6 M), P < 0.01.

Figure 15: Comparison of alkaline phosphatase (ALP) staining ofCOX-2 wild type
(WT) and knockout (KO) primary calvarial cell cultures. Cells were grown for 6 and 9
days before staining.

Figure 16: Effects of exogenous PGE2 (10-6 M) on alkaline phosphates (ALP) activity in
COX-2 wild type (WT) and knockout (KO) primary calvarial cell cultures. PGE2 was
added at the beginning of culture and at each medium change. ALP activity was
n1easured for days 7 and 14 in two different experiments. Data are means
wells.
b

a

± SEM for 3

Significant difference from WI (treated in corresponding manner), P < 0.05.

Significant effect of PGE2 (10-6 M), P < 0.01.
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Figure 17: Effects of exogenous PGE2 (10-6 M) on alkaline phosphatase (ALP) staining
in COX-2 wild type (WT) and knockout (KO) primary calvarial cell cultures on day 7 of
culture. PGE2 was added at the beginning of culture and at each medium change.

Figure 18: Effects of exogenous PGE2 (10-6 M) on alkaline phosphatase (ALP) activity
in COX-2 wild type (WT) and knockout (KO) primary calvarial cell cultures. PGE2 was
added at the beginning of culture and at each medium change. ALP activity was
measured on days 7 and 14 of culture. Data are means ± SEM for 6 wells.
difference from WT (treated in corresponding manner), P < 0.05.

b

a

Significant

Significant effect of

PGE2 (10-6 M), P < 0.01.

Figure 19: Effects of exogenous PGE2 (10-6 M) on alkaline phosphatase (ALP) staining
in COX-2 wild type (WT) and knockout (KO) primary calvarial cell cultures. PGE2 was
added at the beginning of culture and at each medium change.

Figure 20: Effects of exogenous PGE2 (10-7 M) on alkaline phosphatase (ALP) staining
in COX-2 wild type (WT) and knockout (KO) primary calvarial cell cultures. PGE2 was
added at the beginning of culture and at each medium change.
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